seed
Stage
1
Investors
About
SciBase develops medical diagnostic devices that use electrical impedance spectroscopy to assist in the detection of skin cancer, including melanoma (commercial product: Nevisense). The company's technology is focused on improving dermatological diagnostics through non-invasive measurements of skin lesions.
Explore SciBase's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.